Setrobuvir
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
1071517-39-9
Chemical name
Setrobuvir
Molecular formula
C25H25FN4O6S2
Molecular weight
560.6 g/mol
Synonyms
setrobuvirum; Setrobuvir [USAN]; Setrobuvir (USAN); N-[3-[(4aR,5S,8R,8aS)-1-[(4-Fluorophenyl)methyl]-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl]methanesulfonamide; N-(3-((4aR,5S,8R,8aS)-1-(4-Fluorobenzyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7,8,8a-octahydro-5,8-methanoquinolin-3-yl)-1,1-dioxido-4H-benzo[e][1,2,4]thiadiazin-7-yl)methanesulfonamide; Setrobuvir [USAN:INN]; Setrobuvir [INN]; RO 5466731; SETROBUVIR [WHO-DD]; ANA 598; Methanesulfonamide, N-(3-((4aR,5S,8R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-4-hydroxy-2-oxo-5,8-methanoquinolin-3-yl)-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl)-; N-[3-[(1R,2S,7R,8S)-3-[(4-fluorophenyl)methyl]-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.02,7]undec-5-en-5-yl]-1,1-dioxo-4H-1|E6,2,4-benzothiadiazin-7-yl]methanesulfonamide
InChIKey
DEKOYVOWOVJMPM-RLHIPHHXSA-N
PubChem CID
135565932
No GHS reference data is available in the current MolGraph catalog record.
Appearance
Powder or crystals
Catalog reference value; verify against supplier SDS before use.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.